Volumetric parameters of the primary tumor and whole-body tumor burden derived from baseline F-FDG PET/CT can predict overall survival in non-small cell lung cancer patients: initial results from a single institution.

Background: Metabolic tumor volume (MTV) and total lesion glycolysis (TLG) are volumetric parameters derived from F-FDG PET/CT, suggested to have a prognostic value in cancer patients. Our study aimed to test whether these volumetric parameters of the primary tumor and whole-body tumor burden (WBTB) can predict overall survival (OS) in non-small cell lung cancer (NSCLC) patients.

Materials And Methods: Thirty biopsy-proven NSCLC patients who had not begun anti-tumor therapy were included in this prospective study.